X0306 4 2020-02-27 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001738701 Patel Chirag K. C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD, 3RD FLOOR BRIDGEWATER NJ 08807 1 1 1 0 President, Co-CEO & Director Performance-Based Restricted Stock Units 2020-02-27 4 A 0 1266490 0.00 A Class A Common Stock 1266490 1266490 D Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Represents the maximum number of shares issuable under the performance-based restricted stock units. 25% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. An additional 12.5% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10, $12, $14, $16, $18 and $20, respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 28, 2023, the last day of the performance period. Exhibit 24 - Power of Attorney /s/ Meredith Cook, Attorney-in-Fact 2020-03-02